Clinical Trials Directory

Trials / Unknown

UnknownNCT05112510

Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging

Prognostic Prediction of Nasopharyngeal Carcinoma Based on Radiomics Features of MR Diffusion-weighted Imaging

Status
Unknown
Phase
Study type
Observational
Enrollment
125 (estimated)
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore whether the imaging model based on RESOLVE-DWI sequence can exploiting the heterogeneity of nasopharyngeal carcinoma and indicate the prognosis, so as to provide intervention information for clinical decision-making. All patients were randomly divided into the training group and the validation group. Radiomics features extracted from T2-weighted, DWI, apparent diffusion coefficient (ADC), and contrast- enhanced T1-weighted were used to build a radiomics model. Patients'clinical variables were also obtained to build a clinical model. Model of training cohort was established using cross-validation for nasopharyngeal carcinoma prognosis by machine learning, including Logistics Regression, SVM, KNN, Decision Tree, Random Forest, XGBoost, and then, the model will be verified in the validation cohort. Area under the curve (AUC) of the Machine learning model was used as the main evaluation metric.

Conditions

Interventions

TypeNameDescription
OTHERObserving whether developing distant metastasis or recurrenceThe study is a observational study and has no intervention.

Timeline

Start date
2021-06-01
Primary completion
2022-03-01
Completion
2022-06-01
First posted
2021-11-09
Last updated
2021-11-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05112510. Inclusion in this directory is not an endorsement.

Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging (NCT05112510) · Clinical Trials Directory